---
title: "盈利快报：Hims & Hers Health 第一季度盈利因利润压力受到影响；第二季度收入有所提升"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/285996549.md"
description: "Hims & Hers Health 报告称第一季度的收益受到利润压力的影响，但预计第二季度收入将增加。该公司正在经历稳定，这可能导致市场紧缩。最近关于 GLP-1 复合药物的 FDA 裁决可能对 Hims 有利，并且评级上调已被提及。此外，还提供了关于被做空医疗股的见解"
datetime: "2026-05-11T20:59:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285996549.md)
  - [en](https://longbridge.com/en/news/285996549.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285996549.md)
---

# 盈利快报：Hims & Hers Health 第一季度盈利因利润压力受到影响；第二季度收入有所提升

More on Hims & Hers Health Hims Earnings: Stability Could Trigger A Squeeze Hims & Hers, Novo Nordisk: FDA GLP-1 Compounding Ruling May Actually Favor Hims FDA Peptide Review, A Big Moment For Hims & Hers (Rating Upgrade) Hims & Hers Health Q1 2026 Earnings Preview Most and least shorted mid-to mega-cap healthcare stocks in May

### 相关股票

- [HIMS.US](https://longbridge.com/zh-CN/quote/HIMS.US.md)
- [XLV.US](https://longbridge.com/zh-CN/quote/XLV.US.md)
- [VHT.US](https://longbridge.com/zh-CN/quote/VHT.US.md)
- [IHF.US](https://longbridge.com/zh-CN/quote/IHF.US.md)
- [HIMZ.US](https://longbridge.com/zh-CN/quote/HIMZ.US.md)
- [HIMY.US](https://longbridge.com/zh-CN/quote/HIMY.US.md)
- [NVO.US](https://longbridge.com/zh-CN/quote/NVO.US.md)

## 相关资讯与研究

- [瑞银上调爵士制药评级：核心业务韧性强劲，新药 Ziihera 成增长引擎](https://longbridge.com/zh-CN/news/286920691.md)
- [HIMS 又崩了！](https://longbridge.com/zh-CN/news/286084969.md)
- [拿下 4600 家医院客户！安得医疗冲刺港股，血管通路产品跻身全球第一梯队 | 港 E 声](https://longbridge.com/zh-CN/news/287042745.md)
- [【IPO 速递】药物输送龙头安得医疗闯港股，收入两年连降、连续三年分红](https://longbridge.com/zh-CN/news/286726988.md)
- [伯纳姆扬言若接替斯塔默上台，将推翻私有化政策、终结紧缩财政](https://longbridge.com/zh-CN/news/286872627.md)